Search Results

Display Settings
Results per page: 50
Sort By: Relevance
Filter
  • 1-34 of  34 results for ""GLUCAGON-like peptide-1 receptor""

Your Filters

Publication : acta diabetologica Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.

  • Authors : Ciardullo S; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Milan, Italy. .; Department of Medicine and Rehabilitation, Policlinico di Monza, Via Modigliani 10, 20900, Monza, Italy. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Receptors, Gastrointestinal Hormone*/Receptors, Gastrointestinal Hormone*/Receptors, Gastrointestinal Hormone*/agonists

  • Source: Acta diabetologica [Acta Diabetol] 2024 Aug; Vol. 61 (8), pp. 941-950. Date of Electronic Publication: 2024 Jun 03.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists.

  • Authors : Hernández C; Department of Endocrinology, Vall d'Hebron University Hospital, Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes Y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain.

Subjects: Diabetes Mellitus, Type 2* ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists; Biomarkers

  • Source: Acta diabetologica [Acta Diabetol] 2022 Nov; Vol. 59 (11), pp. 1437-1442. Date of Electronic Publication: 2022 Aug 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.

  • Authors : Diallo A; University Montpellier, 80 Avenue Augustin Fliche, 34295, Montpellier Cedex 5, France. .; Carlos-Bolumbu M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Acta diabetologica [Acta Diabetol] 2023 Dec; Vol. 60 (12), pp. 1651-1662. Date of Electronic Publication: 2023 Jul 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 receptor agonists (GLP1-RA) in the treatment of mitochondrial diabetes.

  • Authors : Lebbar M; Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Lyon, France.; Timsit J

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptide-1 Receptor*; DNA, Mitochondrial

  • Source: Acta diabetologica [Acta Diabetol] 2021 Sep; Vol. 58 (9), pp. 1281-1282. Date of Electronic Publication: 2021 May 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.

  • Authors : Oezer K; 5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. .; Kolibabka M

Subjects: Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/drug therapy ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/etiology ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/metabolism

  • Source: Acta diabetologica [Acta Diabetol] 2023 Nov; Vol. 60 (11), pp. 1551-1565. Date of Electronic Publication: 2023 Jul 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?

  • Authors : Menghini R; Departments of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy. .; Casagrande V

Subjects: Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2023 Nov; Vol. 60 (11), pp. 1441-1448. Date of Electronic Publication: 2023 Jul 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus.

  • Authors : Berra C; Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, Milan, Italy. .; Manfrini R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Acta diabetologica [Acta Diabetol] 2023 Sep; Vol. 60 (9), pp. 1257-1266. Date of Electronic Publication: 2023 Jun 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy.

  • Authors : Zaitoon H; Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, 6 Weizmann St, 64239-06, Tel Aviv, Israel.; Lubetzky R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Metformin*/Metformin*/Metformin*/therapeutic use ; Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/drug therapy

  • Source: Acta diabetologica [Acta Diabetol] 2023 Aug; Vol. 60 (8), pp. 1099-1108. Date of Electronic Publication: 2023 May 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.

  • Authors : Falcetta P; Department of Clinical and Experimental Medicine, University of Pisa, 56124, Pisa, Italy.; Nicolì F

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Male ; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 53-60. Date of Electronic Publication: 2022 Sep 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

  • Authors : Burlina S; Department of Medicine - DIMED, University of Padua, Padua, Italy.; Dalfrà MG

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Female

  • Source: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 137-138. Date of Electronic Publication: 2022 Sep 22.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database.

  • Authors : Rathmann W; Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany. .; Kostev K

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Acta diabetologica [Acta Diabetol] 2022 Nov; Vol. 59 (11), pp. 1443-1451. Date of Electronic Publication: 2022 Aug 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data.

  • Authors : Kuss O; Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. .; Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. .

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2022 Oct; Vol. 59 (10), pp. 1349-1359. Date of Electronic Publication: 2022 Jul 25.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.

  • Authors : Ding C; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Tang Y

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Thiazolidinediones*/Thiazolidinediones*/Thiazolidinediones*/therapeutic use; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2022 Apr; Vol. 59 (4), pp. 519-533. Date of Electronic Publication: 2022 Jan 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

  • Authors : Dicembrini I; Diabetology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Via delle Oblate 4, 50141, Florence, Italy.; Nreu B

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2017 Oct; Vol. 54 (10), pp. 933-941. Date of Electronic Publication: 2017 Jul 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.

  • Authors : Jin Y; Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050017, Hebei, People's Republic of China.; Endocrinology Department, Hebei General Hospital, Shijiazhuang, 050051, Hebei, People's Republic of China.

Subjects: Cognition/Cognition/Cognition/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2020 Oct; Vol. 57 (10), pp. 1129-1144. Date of Electronic Publication: 2020 Apr 16.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Trend 2010-2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy.

  • Authors : Fadini GP; Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. .; Division of Metabolic Diseases, Padova Hospital, 35128, Padua, Italy. .

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage

  • Source: Acta diabetologica [Acta Diabetol] 2020 Mar; Vol. 57 (3), pp. 367-375. Date of Electronic Publication: 2019 Oct 31.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.

Subjects: GLUCAGON-like peptide-1 receptor; NLRP3 protein; GLUCAGON-like peptide-1 agonists

  • Source: Acta Diabetologica; Feb2024, Vol. 61 Issue 2, p225-234, 10p

Record details

Read More Add to Saved list
×
Academic Journal

Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis.

  • Authors : Marchesini G; SSD Malattie del Metabolismo e Dietetica Clinica, Università 'Alma Mater', Bologna, Italy. .; Department of Medical & Surgical Sciences, 'Alma Mater' University, S. Orsola-Malpighi Hospital, Via Massarenti, 9, 40138, Bologna, Italy. .

Subjects: Dosage Forms*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology

  • Source: Acta diabetologica [Acta Diabetol] 2019 Mar; Vol. 56 (3), pp. 289-299. Date of Electronic Publication: 2018 Oct 10.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.

  • Authors : Moonschi FH; Department of Chemistry, University of Kentucky, Lexington, KY, 40506, USA.; Hughes CB

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*diagnosis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*physiology

  • Source: Acta diabetologica [Acta Diabetol] 2018 May; Vol. 55 (5), pp. 405-418. Date of Electronic Publication: 2017 Dec 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials.

  • Authors : Monami M; Diabetology, Careggi Teaching Hospital, Azienda Ospedaliero-Universitaria Careggi, Via delle Oblate 4, 50141, Florence, Italy. .; Dicembrini I

Subjects: Biomarkers, Pharmacological/Biomarkers, Pharmacological/Biomarkers, Pharmacological/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology

  • Source: Acta diabetologica [Acta Diabetol] 2017 Dec; Vol. 54 (12), pp. 1101-1114. Date of Electronic Publication: 2017 Sep 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Species differences in pancreatic binding of DO3A-VS-Cys 40 -Exendin4.

  • Authors : Eriksson O; Department of Medicinal Chemistry, Uppsala University, Dag Hammarskjölds väg 14C, 3tr, SE-751 83, Uppsala, Sweden. .; Rosenström U

Subjects: Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism ; Heterocyclic Compounds, 1-Ring/Heterocyclic Compounds, 1-Ring/Heterocyclic Compounds, 1-Ring/*pharmacokinetics ; Insulin-Secreting Cells/Insulin-Secreting Cells/Insulin-Secreting Cells/*metabolism

  • Source: Acta diabetologica [Acta Diabetol] 2017 Nov; Vol. 54 (11), pp. 1039-1045. Date of Electronic Publication: 2017 Sep 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of GW002, a novel recombinant human glucagon-like peptide-1 (GLP-1) analog fusion protein, on CHO recombinant cells and BKS-db mice.

  • Authors : Ji WW; Jiangsu T-mab BioPharma Co., Ltd, G03, 1# Yao-Cheng Avenue, Taizhou, Jiangsu, People's Republic of China.; Yu DA

Subjects: Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*analogs & derivatives

  • Source: Acta diabetologica [Acta Diabetol] 2017 Jul; Vol. 54 (7), pp. 685-693. Date of Electronic Publication: 2017 Apr 19.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach.

  • Authors : Crisci I; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Nuovo Ospedale Santa Chiara, Via Paradisa, 2, 56124, Pisa, Italy.; Aragona M

Subjects: Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2015 Dec; Vol. 52 (6), pp. 1129-33. Date of Electronic Publication: 2015 Aug 21.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.

Subjects: GLUCAGON receptors; TYPE 1 diabetes; GLUCAGON-like peptide-1 receptor

  • Source: Acta Diabetologica; Jan2023, Vol. 60 Issue 1, p19-28, 10p

Record details

Read More Add to Saved list
×
Academic Journal

Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study.

  • Authors : Morano S; Department of Experimental Medicine, Policlinico Umberto I, 'Sapienza' University of Rome, Viale del Policlinico 155, 00161, Rome, Italy, .; Romagnoli E

Subjects: Body Fat Distribution*; Adipose Tissue/Adipose Tissue/Adipose Tissue/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Acta diabetologica [Acta Diabetol] 2015 Aug; Vol. 52 (4), pp. 727-32. Date of Electronic Publication: 2015 Jan 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1 receptor agonist-induced polyarthritis: a case report.

  • Authors : Ambrosio ML; Geriatric Cardiology, Azienda Ospedaliero-Universitaria Careggi, Via delle Oblate 4, 50141, Florence, Italy.; Monami M

Subjects: Arthritis/Arthritis/Arthritis/*etiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*analogs & derivatives

  • Source: Acta diabetologica [Acta Diabetol] 2014 Aug; Vol. 51 (4), pp. 673-4. Date of Electronic Publication: 2013 Oct 25.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide.

  • Authors : Faurschou A; Diabetes Research Division, Department of Internal Medicine F, Gentofte Hospital, University of Copenhagen, Niels Andersens Vej 65, 2900, Hellerup, Denmark, .; Knop FK

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*analogs & derivatives ; Psoriasis/Psoriasis/Psoriasis/*drug therapy

  • Source: Acta diabetologica [Acta Diabetol] 2014 Feb; Vol. 51 (1), pp. 147-50. Date of Electronic Publication: 2011 Dec 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.

  • Authors : Fehmann HC; Department of Medicine, Philipps-University, Marburg, Germany.; Janssen M

Subjects: Galanin/Galanin/Galanin/*pharmacology ; Glucagon/Glucagon/Glucagon/*metabolism ; Glucagon/Glucagon/Glucagon/*pharmacology

  • Source: Acta diabetologica [Acta Diabetol] 1995 Oct; Vol. 32 (3), pp. 176-81.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print Cited Medium: Print ISSN: 0940-5429 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.

Subjects: METFORMIN; GLYCEMIC index; TYPE 2 diabetes

  • Source: Acta Diabetologica; May2021, Vol. 58 Issue 5, p595-602, 8p

Record details

Read More Add to Saved list
×
Academic Journal

Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis.

Subjects: SODIUM-glucose cotransporters; TYPE 2 diabetes; BLOOD sugar

  • Source: Acta Diabetologica; Jan2021, Vol. 58 Issue 1, p5-18, 14p

Record details

Read More Add to Saved list
×
Academic Journal

Species differences in pancreatic binding of DO3A-VS-Cys-Exendin4.

Subjects: PANCREATIC beta cells; GLUCAGON-like peptide-1 receptor; AUTORADIOGRAPHY

  • Source: Acta Diabetologica; Nov2017, Vol. 54 Issue 11, p1039-1045, 7p

Record details

Read More Add to Saved list
×
Academic Journal

Alternative methods for assessing glycemia might prove useful in cases of discordance between glycated hemoglobin and self-monitoring of blood glucose.

Subjects: GLYCOSYLATED hemoglobin; BLOOD sugar monitoring; GLYCEMIC index

  • Source: Acta Diabetologica; Dec2020, Vol. 57 Issue 12, p1523-1524, 2p

Record details

Read More Add to Saved list
×
Academic Journal

Achieving glycemic control in patients with type 2 diabetes and renal impairment.

Subjects: TYPE 2 diabetes prevention; CHRONIC kidney failure; HYPOGLYCEMIA treatment

  • Source: Acta Diabetologica; Jun2013, Vol. 50 Issue 3, p283-291, 9p, 2 Diagrams, 2 Charts, 1 Graph

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.

  • Authors : Bizino MB; Department of Radiology, Leiden University Medical Center, LUMC Postzone C2S, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. .; Jazet IM

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*ethnology ; Glycemic Control/Glycemic Control/Glycemic Control/*statistics & numerical data

  • Source: Acta diabetologica [Acta Diabetol] 2021 Apr; Vol. 58 (4), pp. 485-493. Date of Electronic Publication: 2021 Jan 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-34 of  34 results for ""GLUCAGON-like peptide-1 receptor""